Morgan Stanley’s iShares iBonds Dec 2033 Term Corporate ETF IBDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.2M Buy
2,336,734
+75,234
+3% +$1.94M ﹤0.01% 2042
2026
Q1
$58.5M Buy
2,261,500
+269,846
+14% +$7.04M ﹤0.01% 1936
2025
Q4
$52.1M Buy
1,991,654
+479,160
+32% +$12.6M ﹤0.01% 2041
2025
Q3
$39.7M Buy
1,512,494
+552,741
+58% +$14.3M ﹤0.01% 2216
2025
Q2
$24.9M Buy
959,753
+96,809
+11% +$2.46M ﹤0.01% 2589
2025
Q1
$22.1M Buy
862,944
+104,515
+14% +$2.64M ﹤0.01% 2594
2024
Q4
$19M Buy
758,429
+128,764
+20% +$3.3M ﹤0.01% 2798
2024
Q3
$16.6M Buy
629,665
+113,099
+22% +$2.93M ﹤0.01% 2976
2024
Q2
$13M Buy
516,566
+15,096
+3% +$378K ﹤0.01% 3109
2024
Q1
$12.8M Buy
501,470
+96,268
+24% +$2.45M ﹤0.01% 3136
2023
Q4
$10.5M Buy
405,202
+172,913
+74% +$4.23M ﹤0.01% 3298
2023
Q3
$5.57M Buy
+232,289
New +$5.73M ﹤0.01% 3654

Other funds holding IBDY

Morgan Stanley's IBDY Position: Q2 2026 in Review

Morgan Stanley increased its iShares iBonds Dec 2033 Term Corporate ETF (IBDY) stake by 3.3% in Q2 2026, buying an estimated $1.94M and bringing the position to 2,336,734 shares worth $60.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2042.

Morgan Stanley first reported a position in IBDY in Q3 2023 and has held it in 12 quarters since. 168 funds tracked by Wall St. Rank hold IBDY as of Q2 2026.

  • Morgan Stanley held 2,336,734 shares of iShares iBonds Dec 2033 Term Corporate ETF worth $60.2M as of Q2 2026.
  • Morgan Stanley bought 75,234 iShares iBonds Dec 2033 Term Corporate ETF shares in Q2 2026, an estimated $1.94M.
  • iShares iBonds Dec 2033 Term Corporate ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2042 holding.
  • Morgan Stanley first reported a position in iShares iBonds Dec 2033 Term Corporate ETF in Q3 2023 and has held it in 12 quarters since.
  • 168 funds tracked by Wall St. Rank held iShares iBonds Dec 2033 Term Corporate ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.